Nov 10, 2020 / 02:00PM GMT
Keith Weiss - Morgan Stanley, Research Division - Equity Analyst
Good morning, and welcome to the Morgan Stanley Life After COVID Conference. Very pleased to have with us this morning from Akamai Technologies, Dr. Robert Blumofe, the EVP and General Manager of Platform and Enterprise business. My name is Keith Weiss. I lead the Morgan Stanley software research team here in the U.S.
And before we get kicked off with Akamai, I do have to read a brief disclosure. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. The webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For more important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com\researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Excellent. Bobby, thank you for joining us this morning. Really pleased to have you to talk about Akamai.
Akamai Technologies Inc at Morgan Stanley Life After Covid Thematic Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot